| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 89.484 | 109.977 | 129.001 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 89.485 | 109.979 | 129.005 |
| Total Expenses - EUR | - | - | - | - | - | - | 395 | 49.725 | 41.833 | 40.539 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -395 | 39.761 | 68.145 | 88.466 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -395 | 39.008 | 67.046 | 84.596 |
| Employees | - | - | - | - | - | - | 0 | 3 | 3 | 2 |
Check the financial reports for the company - Tabacu Lizymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25 | 638 | 553 | 442 |
| Current Assets | - | - | - | - | - | - | 45 | 41.785 | 69.525 | 87.834 |
| Inventories | - | - | - | - | - | - | 0 | 142 | 142 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 7.719 | 54.396 | 58.547 |
| Cash | - | - | - | - | - | - | 45 | 33.924 | 14.987 | 29.287 |
| Shareholders Funds | - | - | - | - | - | - | -354 | 38.652 | 67.094 | 84.644 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 425 | 3.771 | 2.984 | 3.632 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tabacu Lizymed S.r.l.